Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,622 | 43,576 | 35,442 | 31,474 | 33,886 |
| Marketable Securities | 8,874 | 45 | 50 | 9,858 | 12,039 |
| Receivables | 235 | 77 | 745 | 432 | 443 |
| TOTAL | $40,390 | $45,716 | $38,441 | $43,481 | $48,491 |
| Non-Current Assets | |||||
| PPE Net | 2,018 | 2,104 | 2,245 | 4,854 | 5,310 |
| Intangibles | 57,212 | 57,212 | 57,234 | 57,266 | 57,299 |
| Other Non-Current Assets | 3,182 | 3,451 | 3,099 | 552 | 588 |
| TOTAL | $62,412 | $62,767 | $62,578 | $62,672 | $63,197 |
| Total Assets | $102,802 | $108,483 | $101,019 | $106,153 | $111,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,018 | 5,683 | 6,270 | 5,030 | 4,685 |
| Other current liabilities | 9,142 | N/A | N/A | 9,915 | 1 |
| TOTAL | $15,275 | $16,890 | $17,960 | $15,881 | $16,052 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 10,106 | 10,808 | N/A | 10,379 |
| Other Non-Current Liabilities | 1,781 | 2,090 | 1,918 | 2,095 | 2,278 |
| TOTAL | $20,652 | $20,603 | $21,036 | $23,612 | $24,378 |
| Total Liabilities | $35,927 | $37,493 | $38,996 | $39,493 | $40,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 188,837 | 188,798 | 188,534 | 174,987 | 174,987 |
| Common Shares | 467,928 | 466,571 | 451,343 | 450,282 | 448,249 |
| Retained earnings | -397,158 | -391,398 | -384,856 | -380,081 | -372,971 |
| Other shareholders' equity | -3,895 | -4,183 | -4,464 | -3,541 | -4,020 |
| TOTAL | $66,875 | $70,990 | $62,023 | $66,660 | $71,258 |
| Total Liabilities And Equity | $102,802 | $108,483 | $101,019 | $106,153 | $111,688 |